In the latest twist in the ocean of Zantac-related litigation playing out across state courts, drugmakers have notched a key ...

Delaware's top court reversed a ruling that allowed expert testimony in Zantac cancer lawsuits, citing improper legal ...

Delaware's Supreme Court sides with drugmakers including GSK (GSK) and Pfizer (PFE), rejecting expert testimony linking ...

The Delaware Supreme Court rejected the legitimacy of expert testimony linking the heartburn drug Zantac to cancer, in a ...

Delaware's highest court ruled on Thursday that nearly 75,000 patients suing four large drugmakers cannot introduce reports ...

The case is IN RE Zantac Litigation, No. 255, 2024, Delaware Supreme Court (Dover). ___ With assistance from Ashleigh Furlong.

Over 75,000 plaintiffs filed suit in Delaware Superior Court alleging that ranitidine, which several manufacturers market under the trade name Zantac, caused their cancer. More specifically, they ...

Delaware's highest court said on Tuesday it will hear an appeal by GSK GSK.L and other drug makers seeking to end more than 70,000 lawsuits claiming discontinued heartburn drug Zantac caused cancer.

GSK shares jumped Wednesday on news Delaware’s top court ruled in the pharmaceutical company’s favor, by agreeing to review the admissibility of expert evidence that could play a part in the ...

Delaware's highest court said on Tuesday it will hear an appeal by GSK GSK.L and other drug makers seeking to end more than 70,000 lawsuits claiming discontinued heartburn drug Zantac caused cancer.

Delaware’s highest court agreed to hear an appeal by GSK and other drugmakers seeking to end more than 70,000 lawsuits claiming discontinued heartburn drug Zantac caused cancer, Reuters writes.